| 000 | 01310 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515005709.0 | ||
| 264 | 0 | _c20060808 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a1568-0096 | ||
| 024 | 7 |
_a10.2174/156800905774574075 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDaniel, Kenyon G | |
| 245 | 0 | 0 |
_aAnti-angiogenic and anti-tumor properties of proteasome inhibitors. _h[electronic resource] |
| 260 |
_bCurrent cancer drug targets _cNov 2005 |
||
| 300 |
_a529-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAcetylcysteine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBoronic Acids _xpharmacology |
| 650 | 0 | 4 | _aBortezomib |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xblood supply |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xprevention & control |
| 650 | 0 | 4 |
_aProtease Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aProteasome Inhibitors |
| 650 | 0 | 4 |
_aPyrazines _xpharmacology |
| 700 | 1 | _aKuhn, Deborah J | |
| 700 | 1 | _aKazi, Aslamuzzaman | |
| 700 | 1 | _aDou, Q Ping | |
| 773 | 0 |
_tCurrent cancer drug targets _gvol. 5 _gno. 7 _gp. 529-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/156800905774574075 _zAvailable from publisher's website |
| 999 |
_c15928673 _d15928673 |
||